| pubmed-article:10561276 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C0038250 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C1521721 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C1328050 | lld:lifeskim |
| pubmed-article:10561276 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
| pubmed-article:10561276 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:10561276 | pubmed:dateCreated | 2000-6-7 | lld:pubmed |
| pubmed-article:10561276 | pubmed:abstractText | To determine the safety and feasibility of delivering multiple cycles of front-line high-dose carboplatin and paclitaxel with hematopoietic peripheral-blood stem cell (PBSC) support. | lld:pubmed |
| pubmed-article:10561276 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10561276 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10561276 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10561276 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10561276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10561276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10561276 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10561276 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:10561276 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:JohnsonSS | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:GalliPP | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:LitwinSS | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:OzolsR FRF | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:RogersBB | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:BookmanM AMA | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:SchilderR JRJ | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:MillensonM... | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:RosenblumNN | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:BoenteMM | lld:pubmed |
| pubmed-article:10561276 | pubmed:author | pubmed-author:KindsfatherSS | lld:pubmed |
| pubmed-article:10561276 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10561276 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:10561276 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10561276 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10561276 | pubmed:pagination | 2198-207 | lld:pubmed |
| pubmed-article:10561276 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:meshHeading | pubmed-meshheading:10561276... | lld:pubmed |
| pubmed-article:10561276 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10561276 | pubmed:articleTitle | Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells. | lld:pubmed |
| pubmed-article:10561276 | pubmed:affiliation | Fox Chase Cancer Center, Philadelphia, PA 19111, USA. rj_schilder@fccc.edu | lld:pubmed |
| pubmed-article:10561276 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10561276 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10561276 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10561276 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10561276 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
